MERIT Act
- Introduced Jan 9
- Committee Jan 9
- Passed House Next
- Passed Senate Not yet
- To President Not yet
- Law Not yet
Where it stands
In committee, Jan 9, 2023Next: House vote
678d ago Dec 19, 2024: Placed on the Union Calendar, Calendar No. 779.
Final votes
No roll callsNo recorded vote on this bill yet
Member trades
0trades in the last 90 days
None in these companies
Who backs the bill and who pushes back Subscribe
Companies lobbying on this bill
1 companyCompanies by sector
Biotech & Pharma 1
Search all 1 companies, their asks and price moves Subscribe
Votes
No recorded roll-call vote on this bill yet
Member trades
No member of Congress traded these companies in the last 90 days
Summary
Mandating Exclusive Review of Individual Treatments (MERIT) Act
Full summary1 paragraphs
This bill specifies that coverage determinations for drugs and biologics under Medicare must be made with respect to each drug or biologic, rather than with respect to a class of drugs or biologics.
Library of Congress summary, Jan 9, 2023
Summary versions
- Introduced in HouseJan 9, 2023
Actions
- HouseCommittee on Ways and Means discharged.Dec 19, 2024
- HousePlaced on the Union Calendar, Calendar No. 779.Dec 19, 2024
- HouseReferred to the Subcommittee on Health.Dec 17, 2024
- HouseReported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-764, Part I.Nov 22, 2024
- HouseHouse Committee on Ways and Means Granted an extension for further consideration ending not later than Dec. 19, 2024.Nov 22, 2024
- HouseCommittee Consideration and Mark-up Session HeldDec 6, 2023
- HouseOrdered to be Reported (Amended) by the Yeas and Nays: 42 - 0.Dec 6, 2023
- HouseCommittee Consideration and Mark-up Session HeldDec 5, 2023
- HouseSubcommittee Consideration and Mark-up Session HeldNov 15, 2023
- HouseForwarded by Subcommittee to Full Committee in the Nature of a Substitute (Amended) by Voice Vote.Nov 15, 2023
- HouseReferred to the Subcommittee on Health.Jan 20, 2023
- HouseIntroduced in HouseJan 9, 2023
All actions13
- HouseReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.Jan 9, 2023
Bill record
Text versions2
- Reported in HouseDec 19, 2024PDF: Reported in House
- Introduced in HouseJan 9, 2023PDF: Introduced in House
Committees2
- House Ways and Means CommitteeDischarged From Dec 19, 2024Referred To, Jan 9, 2023
- Subcommittee: Health SubcommitteeReferred to
- House Energy and Commerce CommitteeReported By Nov 22, 2024Markup By, Dec 6, 2023Markup By, Dec 5, 2023Referred To, Jan 9, 2023
- Subcommittee: Health SubcommitteeReported by
- Subcommittee: Communications and Technology SubcommitteeReferred to
Sponsor and cosponsors6 cosponsors
- Rep. Vern Buchanan (R-FL-16)Sponsor, Jan 9, 2023
- Maria Salazar (R-FL-27)OriginalJoined Jan 9, 2023
- Nanette Barragan (D-CA-44)OriginalJoined Jan 9, 2023
- Brian Fitzpatrick (R-PA-1)Joined May 9, 2023
- A. Ferguson (R-GA-3)Joined May 10, 2023
- Mike Carey (R-OH-15)Joined May 11, 2023
- Carol Miller (R-WV-1)Joined Aug 25, 2023
Amendments0
No amendments offered
Cost estimates and reports2
- CBO: H.R. 133, Mandating Exclusive Review of Individual Treatments (MERIT) ActMar 13, 2024As ordered reported by the House Committee on Energy and Commerce on December 6, 2023
- H. Rept. 118-764Committee report
Titles4
Short titles
- MERIT ActShort Title(s) as Reported to House
- Mandating Exclusive Review of Individual Treatments ActShort Title(s) as Reported to House
- Mandating Exclusive Review of Individual Treatments (MERIT) ActShort Title(s) as Introduced
Official titles
- To amend title XVIII of the Social Security Act to clarify the use of the national coverage determination process under the Medicare program.Official Title as Introduced
Subjects4
Related bills1
- H.R. 9127 117th, Reintroduction of Mandating Exclusive Review of Individual Treatments (MERIT) Act
Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 28, 2026.